← Leaderboards
Marshall Stoller
Buck Institute For Research On Aging
$1,889,410
Attributed
$3,644,778
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,515,715 · 6
FDA$2,124,997 · 1
By mechanism
U2C$2,414,540 · 1
R01$2,124,997 · 1
P20$1,715,436 · 2
R21$1,385,739 · 3
Top collaborators
- Tom Chi6 shared
- Elaine Ku3 shared
- Kathleen Miho Sakamoto3 shared
- Sunita P Ho2 shared
- Pankaj Kapahi2 shared
- Heiko Hui Yang1 shared
Most similar at Buck Institute For Research On Aging
Same institution · by research overlap
- Nichole Dinell Bond$53,412
Others in their field
Top investigators on “Urology”
- Charles A Coltman · Southwest Oncology Group$187,603,414
- Laurence H Baker · University Of Michigan At Ann Arbor$125,467,520
- John J Crowley · Fred Hutchinson Cancer Research Center$50,420,733
- J Richard Landis · University Of Pennsylvania$36,125,401
- David Heimbrook · Leidos Biomedical Research, Inc.$32,281,639
- Richard T D'aquila · Massachusetts General Hospital$27,454,413
Research focus
UrologyDisciplineBenignAffectUniversitiesUrinary CalculiCaliforniaKidney CalculiSan FranciscoProgramsMetalsMineralizationMorbidity - Disease RateDrosophila MelanogasterResearch PersonnelPlayFunctional DisorderInstitutionInterdisciplinary StudyPhysiologyLeadershipClinicGeneticCalculi
Grant awards (24)
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology$832,600
U2C · FY2025 · DK
Lumbricus terrestris erythrocruorin (LtEc) as a red blood cell substitute in normothermic ex vivo kidney perfusion$423,017
R21 · FY2025 · DK · contact PI
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology$749,339
U2C · FY2024 · DK
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology$832,601
U2C · FY2023 · DK
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)$499,999
R01 · FY2022 · FD · contact PI
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)$499,999
R01 · FY2021 · FD · contact PI
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)$53,976
R01 · FY2021 · FD · contact PI
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)$499,999
R01 · FY2020 · FD · contact PI
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)$71,025
R01 · FY2020 · FD · contact PI
Phase 2: Impact of Lipoic Acid on Cystine Nephrolithiasis; IND129545 (01/29/2016)$499,999
R01 · FY2017 · FD · contact PI
Multiscale form and function can predict renal biomineralization$198,125
R21 · FY2017 · DK
Optimizing Kidney Stone Management Using Metallomics and Metabolomics$311,955
P20 · FY2016 · DK · contact PI
Multiscale form and function can predict renal biomineralization$236,850
R21 · FY2016 · DK
Optimizing Kidney Stone Management Using Metallomics and Metabolomics$67,047
P20 · FY2016 · DK · contact PI
Optimizing Kidney Stone Management Using Metallomics and Metabolomics$58,962
P20 · FY2016 · DK · contact PI
Optimizing Kidney Stone Management Using Metallomics and Metabolomics$317,000
P20 · FY2015 · DK · contact PI
Optimizing Kidney Stone Management Using Metallomics and Metabolomics$66,995
P20 · FY2015 · DK · contact PI
A Drosophila Model Investigates the Role of Metals in Initiating Urinary Stones$15,838
P20 · FY2015 · DK · contact PI
A Drosophila Model Investigates the Role of Metals in Initiating Urinary Stones$317,574
P20 · FY2014 · DK · contact PI
A Drosophila Model Investigates the Role of Metals in Initiating Urinary Stones$180,000
P20 · FY2014 · DK · contact PI
A Drosophila Model Investigates the Role of Metals in Initiating Urinary Stones$34,770
P20 · FY2014 · DK · contact PI
A Drosophila Model Investigates the Role of Metals in Initiating Urinary Stones$345,295
P20 · FY2013 · DK · contact PI
A model of kidney stone disease using D. melanogaster$271,703
R21 · FY2013 · DK
A model of kidney stone disease using D. melanogaster$256,044
R21 · FY2012 · DK